Avotermin

Basic Information


CAS ID: 182212-66-4
Molecular Formula:
Molecular Weight: g/mol
Monoisotopic Mass: g/mol
Class: Protein based biotech
Natural Product: No
Other Names: AVOTERMIN
Analysis: N/A


Compound Structure and Identifier


InChI: See All
InChI Key:
Smiles: See All
Molfile:


Related Target



Related Fibrosis Property


Trial Record 1

ClinicalTrial ID NCT00984581 Disease Scar
Phase Phase 1,Phase 2 Status Completed
First Received September 25, 2009 Last Verified September 25, 2009
Sponsor Renovo

Trial Record 2

ClinicalTrial ID NCT00984503 Disease Scar
Phase Phase 2 Status Completed
First Received September 25, 2009 Last Verified September 25, 2009
Sponsor Renovo

Trial Record 3

ClinicalTrial ID NCT00978367 Disease Scar
Phase Phase 1,Phase 2 Status Completed
First Received September 16, 2009 Last Verified September 16, 2009
Sponsor Renovo

Trial Record 4

ClinicalTrial ID NCT00978302 Disease Scar
Phase Phase 1 Status Completed
First Received September 16, 2009 Last Verified September 16, 2009
Sponsor Renovo

Trial Record 5

ClinicalTrial ID NCT00977951 Disease Scar
Phase Phase 1,Phase 2 Status Completed
First Received September 16, 2009 Last Verified September 16, 2009
Sponsor Renovo

Trial Record 6

ClinicalTrial ID NCT00847925 Disease Scar
Phase Phase 1,Phase 2 Status Completed
First Received February 19, 2009 Last Verified February 19, 2009
Sponsor Renovo

Trial Record 7

ClinicalTrial ID NCT00847795 Disease Scar
Phase Phase 1,Phase 2 Status Completed
First Received February 19, 2009 Last Verified February 19, 2009
Sponsor Renovo

Trial Record 8

ClinicalTrial ID NCT00742443 Disease Scar
Phase Phase 3 Status Completed
First Received August 27, 2008 Last Verified March 3, 2011
Sponsor Renovo

Trial Record 9

ClinicalTrial ID NCT00651820 Disease Scar
Phase Phase 4 Status Completed
First Received April 3, 2008 Last Verified June 9, 2011
Sponsor Healthpoint

Trial Record 10

ClinicalTrial ID NCT00629811 Disease Scar
Phase Phase 2 Status Completed
First Received March 6, 2008 Last Verified March 6, 2008
Sponsor Renovo

Trial Record 11

ClinicalTrial ID NCT00627536 Disease Scar
Phase Phase 2 Status Completed
First Received March 3, 2008 Last Verified March 4, 2008
Sponsor Renovo

Trial Record 12

ClinicalTrial ID NCT00594581 Disease Scar
Phase Phase 2 Status Completed
First Received January 15, 2008 Last Verified January 15, 2008
Sponsor Renovo

Trial Record 13

ClinicalTrial ID NCT00436449 Disease Scar
Phase Phase 2 Status Completed
First Received February 19, 2007 Last Verified August 14, 2008
Sponsor Renovo

Trial Record 14

ClinicalTrial ID NCT00432328 Disease Scar
Phase Phase 2 Status Terminated
First Received February 7, 2007 Last Verified January 13, 2009
Sponsor Renovo

Trial Record 15

ClinicalTrial ID NCT00432211 Disease Scar
Phase Phase 2 Status Unknown
First Received February 7, 2007 Last Verified February 4, 2009
Sponsor Renovo

Trial Record 16

ClinicalTrial ID NCT00430326 Disease Scar
Phase Phase 2 Status Completed
First Received February 1, 2007 Last Verified March 9, 2010
Sponsor Renovo

Trial Record 17

ClinicalTrial ID NCT00836147 Disease Keloid
Phase Phase 1,Phase 2 Status Completed
First Received February 4, 2009 Last Verified September 28, 2010
Sponsor Renovo

Trial Record 18

ClinicalTrial ID NCT00710333 Disease Keloid
Phase Phase 1,Phase 2 Status Completed
First Received July 4, 2008 Last Verified March 9, 2010
Sponsor Renovo

Trial Record 19

ClinicalTrial ID NCT00656227 Disease Scar
Phase Phase 2 Status Unknown
First Received April 11, 2008 Last Verified April 11, 2008
Sponsor Renovo

Trial Record 20

ClinicalTrial ID NCT00469235 Disease Keloid
Phase Phase 1,Phase 2 Status Completed
First Received May 4, 2007 Last Verified September 16, 2009
Sponsor Renovo

Related Link


PubChem: 135339352
ChEMBL: CHEMBL2108833